“…Hypervolemia subgroup patients (table III) also showed excellent benefits with the strategy used. After completion of protocol, there was a significant improvement of cardiac index (a 42.7% increase, with median varying from 1.85 ± 0.59 l/min/m 2 to 2.64 ± 0.75 l/min/m 2 ), reduction of SVRI in 40% (from 2,972 ± 1,259.3 dynes/s/cm -5 /m 2 to 1,784 ± 781.3 dynes/s/cm -5 /m 2 ), decrease of PWP in 37.7% (from 26.5 ± 8.5 mmHg to 16.5 ± 4 mmHg) and CVP in 38.4% (from 13 ± 4.5 mmHg to 8 ± (9,17,18) showed initial PWP between 20 mmHg and 15 mmHg and were considered as hypervolemic and decompensate. The same strategy for those with PWP > 20 mmHg was used, which resulted in an expressive increase of cardiac index in the three of them and a decrease in peripheral vascular resistance in the last two.…”